Tudor Investment Corp’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Buy
101,611
+73,075
+256% +$8.65M 0.02% 674
2025
Q4
$3.85M Sell
28,536
-4,347
-13% -$474K 0.01% 1318
2025
Q3
$2.79M Buy
+32,883
New +$2.02M ﹤0.01% 1590
2024
Q1
Sell
-24,500
Closed -$262K 2153
2023
Q4
$262K Buy
+24,500
New +$250K ﹤0.01% 2091

Other funds holding ABVX

Tudor Investment Corp's ABVX Position: Q1 2026 in Review

Tudor Investment Corp increased its Abivax (ABVX) stake by 256% in Q1 2026, buying an estimated $8.65M and bringing the position to 101,611 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #674.

Tudor Investment Corp first reported a position in ABVX in Q4 2023 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Tudor Investment Corp held 101,611 shares of Abivax worth $11.3M as of Q1 2026.
  • Tudor Investment Corp bought 73,075 Abivax shares in Q1 2026, an estimated $8.65M.
  • Abivax made up 0.02% of Tudor Investment Corp's portfolio in Q1 2026, its #674 holding.
  • Tudor Investment Corp first reported a position in Abivax in Q4 2023 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.